BRIEF-Enanta Pharmaceuticals In Patent Infringement Action Against Pfizer

2

Oct 29 (Reuters) – Enanta Pharmaceuticals Inc: * ENANTA PHARMACEUTICALS INC: IN PATENT INFRINGEMENT ACTION AGAINST PFIZER RELATED TO INFRINGEMENT, UPC RULES '265 PATENT INVALID – SEC FILING * ENANTA

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)